Infectious Disease
Infectious diseases cause more deaths worldwide than any other single cause.  During the 20th century, methods of treating infectious diseases improved dramatically. Unfortunately, over several decades, antibiotics were over-prescribed, promoting bacteria that are resistant to their effects.  Antimicrobial resistance is known to increase the severity of infectious disease, increase the death rates from certain infections and contribute to rising health care costs.  Antimicrobial resistance is a particularly difficult problem for hospitals with critically ill patients who are less able to fight off infections without the help of antibiotics.  Increasing frequency and severity of disease resulting from pathogens with resistance to multiple antibiotics have created an urgent need for improved diagnostic methods.

GenArraytion's high fidelity pathogen signatures identify infectious disease agents and their antibiotic susceptibility in hours, a fraction of the time required using conventional methods.  Rapid identification of the underlying cause of infection, and knowledge of antibiotic resistance profiles will enable medical professionals to respond quickly with effective antibiotic treatment, rather than the wrong antibiotic, or a cocktail of antibiotics that can promote antimicrobial resistance.  Rapid, accurate diagnosis and treatment are keys to lower mortality and improved outcomes that mean patients get well sooner, thus decreasing medical costs.

Nearly 2 million patients in the United States get an infection in the hospital each year

About 90,000 of those patients die each year as a result of their infection, up from 13,300 patient deaths in 1992

More than 70 percent of the bacteria that cause hospital-acquired infections are resistant to at least one of the antibiotics most commonly used to treat them

People infected with antibiotic-resistant organisms are more likely to have longer hospital stays and require treatment with second- or third-choice medicines that may be less effective, more toxic, and more expensive

Source: http://www.niaid.nih.gov/factsheets/antimicro.htm
©  2008 GenArraytion, Inc.  All Rights Reserved.
home
HOME                        COMPANY                  APPLICATIONS           PRODUCTS & SERVICES           NEWS & EVENTS               CONTACT US               PUBLICATIONS
GenArraytion provides a paradigm-shifting approach that can dramatically impact medical care by improving the quality and speed of infectious disease diagnosis.
MRSA Genotyping Array